Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gentuzumab Ozogamicin Berfore Allogeneic Stem Cell Transplantation in Patients With Relapsed CD33+ Acute Myeloid Leukemia

NCT00460447 is registered in ClinicalTrials.gov with University Hospital Carl Gustav Carus as lead sponsor.

NCT NCT00460447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gentuzumab Ozogamicin Berfore Allogeneic Stem Cell Transplantation in Patients With Relapsed CD33+ Acute Myeloid Leukemia
Lead sponsor
University Hospital Carl Gustav Carus
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2004
Completion date
Not reported
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, allogeneic transplantation